Related Experiment Videos
Noradrenergic and purinergic involvement in spinal antinociception by 5-hydroxytryptamine and
European Journal of Pharmacology
|November 12, 1991
Summary
Spinal antinociception by serotonin (5-HT) and 2-methyl-5-hydroxytryptamine (2-Me-5-HT) involves alpha 2-adrenoceptors. Serotonin
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Serotonin (5-HT) and its analogs mediate antinociception.
- The precise mechanisms of spinal antinociception by 5-HT and 2-Me-5-HT are not fully elucidated.
- Adrenergic and adenosinergic pathways are potential modulators of spinal pain signaling.
Purpose of the Study:
- To investigate the involvement of adrenergic and adenosinergic systems in spinal antinociception induced by 5-HT and 2-Me-5-HT.
- To differentiate the roles of alpha-adrenoceptor subtypes and endogenous noradrenaline.
Main Methods:
- Intrathecal administration of alpha-adrenoceptor antagonists (phentolamine, yohimbine, prazosin) and the neurotoxin 6-hydroxydopamine.
- Assessment of antinociception using tail flick and hot plate tests.
- Evaluation of adenosine receptor involvement using 8-phenyltheophylline.
Main Results:
- Phentolamine and yohimbine, but not prazosin, reduced the antinociceptive effects of both 5-HT and 2-Me-5-HT.
- 6-hydroxydopamine differentially affected 5-HT and 2-Me-5-HT antinociception.
- 8-phenyltheophylline attenuated 5-HT-induced antinociception but not that of 2-Me-5-HT.
Conclusions:
- Spinal antinociception by both 5-HT and 2-Me-5-HT involves alpha 2-adrenoceptors, with distinct interactions.
- 5-HT antinociception is dependent on endogenous noradrenaline, unlike 2-Me-5-HT.
- Adenosine release contributes to 5-HT antinociception but not to 2-Me-5-HT antinociception.